NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.35M, a 6.87% decline year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$12.3M, a 3.87% decline year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$12.3M, a 3.87% decline from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$11.9M, a 18.6% decline from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$10M, a 0.52% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$12.3M -$3.35M -$215K -6.87% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-17
Q2 2024 -$12.1M -$2.77M +$701K +20.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$12.8M -$2.86M +$668K +19% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-14
Q4 2023 -$13.5M -$3.34M -$1.61M -93% Oct 1, 2023 Dec 31, 2023 10-Q 2024-08-14
Q3 2023 -$11.9M -$3.14M -$1.76M -128% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-17
Q2 2023 -$10.1M -$3.47M -$709K -25.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$9.39M -$3.52M -$465K -15.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-14
Q4 2022 -$8.92M -$1.73M +$1.07M +38.3% Oct 1, 2022 Dec 31, 2022 10-Q 2024-08-14
Q3 2022 -$10M -$1.37M +$1.27M +48% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-15
Q2 2022 -$11.3M -$2.76M +$192K +6.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$11.5M -$3.06M -$664K -27.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-14
Q4 2021 -$10.8M -$2.81M -$848K -43.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-08-14
Q3 2021 -$9.95M -$2.64M -$2.08M -367% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-22
Q2 2021 -$7.87M -$2.95M +$4.14M +58.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$12M -$2.39M -$1.05M -77.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-11
Q4 2020 -$11M -$1.96M +$2.68M +57.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-08-11
Q3 2020 -$13.6M -$566K +$787K +58.2% Jul 1, 2020 Sep 30, 2020 10-K/A 2022-05-31
Q2 2020 -$14.4M -$7.09M -$5.23M -281% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$9.2M -$1.35M +$866K +39.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$10.1M -$4.64M -$3.28M -243% Oct 1, 2019 Dec 31, 2019 10-Q 2021-05-14
Q3 2019 -$6.78M -$1.35M Jul 1, 2019 Sep 30, 2019 10-K 2020-12-09
Q2 2019 -$1.86M -$602K -47.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$2.21M -$855K -63% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$1.35M +$273K +16.8% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q2 2018 -$5.19M -$1.26M +$33.3K +2.58% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$5.22M -$1.36M -$627K -86% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$4.59M -$1.63M -$1.62M -86263% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$2.97M -$944K -$932K -7619% Jul 1, 2017 Sep 30, 2017 10-K 2018-04-16
Q2 2017 -$2.04M -$1.29M -$1.27M -5140% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$768K -$730K -$721K -8043% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-16
Q4 2016 -$47.8K -$1.88K +$17.2K +90.1% Oct 1, 2016 Dec 31, 2016 10-K 2017-04-17
Q3 2016 -$65K -$12.2K -$2.17K -21.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$62.8K -$24.7K -$2.55K -11.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$60.2K -$8.96K +$2.62K +22.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 -$62.9K -$19.1K -$9.19K -93.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 -$53.7K -$10.1K -$3.95K -64.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 -$49.7K -$22.1K -$6.13K -38.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-19
Q1 2015 -$43.6K -$11.6K -$7.36K -174% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-23
Q4 2014 -$36.2K -$9.88K -$6.88K -230% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-14
Q3 2014 -$29.4K -$6.12K -$989 -19.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$28.4K -$16K +$3.1K +16.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$31.5K -$4.23K -$920 -27.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 -$30.6K -$2.99K -$1.74K -138% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-15
Q3 2013 -$28.8K -$5.13K -$351 -7.34% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 -$28.5K -$19.1K -$16.8K -713% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-18
Q1 2013 -$11.7K -$3.31K +$2.27K +40.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$14K -$1.26K +$14.3K +91.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-11-19
Q3 2012 -$28.2K -$4.78K -$602 -14.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 -$27.6K -$2.35K -$1.13K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 -$26.5K -$5.57K +$1.12K +16.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$27.6K -$15.5K Oct 1, 2011 Dec 31, 2011 10-Q 2014-11-19
Q3 2011 -$4.18K +$1.02K +19.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$1.22K* +$1.56K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-15
Q1 2011 -$6.69K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$5.2K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$2.78K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.